JPWO2022149487A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022149487A5 JPWO2022149487A5 JP2022574004A JP2022574004A JPWO2022149487A5 JP WO2022149487 A5 JPWO2022149487 A5 JP WO2022149487A5 JP 2022574004 A JP2022574004 A JP 2022574004A JP 2022574004 A JP2022574004 A JP 2022574004A JP WO2022149487 A5 JPWO2022149487 A5 JP WO2022149487A5
- Authority
- JP
- Japan
- Prior art keywords
- ion
- group
- prostate cancer
- trimetyl
- cyclohexenone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021001676 | 2021-01-07 | ||
| JP2021001676 | 2021-01-07 | ||
| PCT/JP2021/048082 WO2022149487A1 (ja) | 2021-01-07 | 2021-12-24 | 前立腺がんの罹患の可能性を検査する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022149487A1 JPWO2022149487A1 (https=) | 2022-07-14 |
| JPWO2022149487A5 true JPWO2022149487A5 (https=) | 2024-12-09 |
| JP7769179B2 JP7769179B2 (ja) | 2025-11-13 |
Family
ID=82357872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022574004A Active JP7769179B2 (ja) | 2021-01-07 | 2021-12-24 | 前立腺がんの罹患の可能性を検査する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240085400A1 (https=) |
| EP (1) | EP4276456A4 (https=) |
| JP (1) | JP7769179B2 (https=) |
| CN (1) | CN116783484A (https=) |
| AU (1) | AU2021417970A1 (https=) |
| TW (1) | TW202242412A (https=) |
| WO (1) | WO2022149487A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013515270A (ja) * | 2009-12-22 | 2013-05-02 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 前立腺癌の代謝学的プロファイリング |
| US20130217647A1 (en) * | 2010-07-28 | 2013-08-22 | Metabolon, Inc. | Biomarkers for Prostate Cancer and Methods Using the Same |
| US20160025734A1 (en) * | 2014-07-23 | 2016-01-28 | Children's Medical Center Corporation | Use of urinary protein biomarkers to distinguish between neoplastic and non-neoplastic disease of the prostate |
| JP2017203649A (ja) * | 2016-05-09 | 2017-11-16 | 国立大学法人大阪大学 | 前立腺がん判定方法 |
| CN108344830B (zh) * | 2017-01-22 | 2020-10-16 | 中国科学院大连化学物理研究所 | 用于诊断前列腺癌的尿样组合标志物及检测试剂盒 |
| US10908162B2 (en) * | 2017-10-27 | 2021-02-02 | The Board Of Regents Of The University Of Texas System | Methods related to volatile compounds in genitourinary cancers |
-
2021
- 2021-12-24 WO PCT/JP2021/048082 patent/WO2022149487A1/ja not_active Ceased
- 2021-12-24 TW TW110148710A patent/TW202242412A/zh unknown
- 2021-12-24 US US18/260,701 patent/US20240085400A1/en active Pending
- 2021-12-24 AU AU2021417970A patent/AU2021417970A1/en active Pending
- 2021-12-24 CN CN202180089607.XA patent/CN116783484A/zh active Pending
- 2021-12-24 JP JP2022574004A patent/JP7769179B2/ja active Active
- 2021-12-24 EP EP21917707.8A patent/EP4276456A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Monleau et al. | Comparison of different extraction techniques to profile microRNAs from human sera and peripheral blood mononuclear cells | |
| Gao et al. | Proteomic analysis of acetaminophen‐induced hepatotoxicity and identification of heme oxygenase 1 as a potential plasma biomarker of liver injury | |
| Boogaard | Use of haemoglobin adducts in exposure monitoring and risk assessment | |
| JP2018509934A5 (https=) | ||
| JP2006509186A5 (https=) | ||
| Ondruschka et al. | Post-mortem in situ stability of serum markers of cerebral damage and acute phase response | |
| Turner et al. | Detection of allantoin in clinical samples using hydrophilic liquid chromatography with stable isotope dilution negative ion tandem mass spectrometry | |
| JP2020514689A5 (https=) | ||
| US20180299448A1 (en) | Colorectal cancer screening method | |
| CN109632780B (zh) | 一种检测atp的比色方法及试剂盒 | |
| CN103630678A (zh) | 男性不育的生物标志物及其应用 | |
| AU8474701A (en) | Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites | |
| Whiteaker et al. | Targeted mass spectrometry enables robust quantification of FANCD2 mono-ubiquitination in response to DNA damage | |
| Boogaard et al. | Urinary metabolites and haemoglobin adducts as biomarkers of exposure to 1, 3-butadiene: a basis for 1, 3-butadiene cancer risk assessment. | |
| JP2019510974A5 (https=) | ||
| Oberpenning et al. | Semi-quantitative immunochromatographic test for prostate specific antigen in whole blood: tossing the coin to predict prostate cancer? | |
| JPWO2022149487A5 (https=) | ||
| Yuan et al. | Liver fibrosis associated with potential vinyl chloride and ethylene dichloride exposure from the petrochemical industry | |
| Natarajan et al. | Liquid chromatography-tandem mass spectrometry method for estimation of a panel of lysophosphatidylcholines in dried blood spots for screening of X-linked adrenoleukodystrophy | |
| JP2007248395A5 (https=) | ||
| JPWO2022072471A5 (https=) | ||
| KR101552011B1 (ko) | 리소포스파티딜콜린 및 호모시스테인산을 포함하는 난소암 진단용 조성물 및 이를 사용하여 난소암을 진단하는 방법 | |
| Silva Dalsasso Joaquim et al. | Analytical validation of an in‐house method for adenosine deaminase determination | |
| KR102838354B1 (ko) | 전복의 해수 염분 변화 환경 노출 여부 판단용 대사물질 조성물 및 이를 이용한 전복의 해수 염분 변화 환경 노출 여부 판단 방법 | |
| WO2014159920A4 (en) | A device and method for the detection and diagnosis of aggressive and metastatic cancer and cancer stem cells employing podocalyxin and tra biomarkers |